Last 12 months
Inside the activity.
2 purchase rows · 80 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 23 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 11 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 2 | 10 |
| Apr 2026 | 0 | 5 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 6 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 13, 2025 Filed Nov 14, 2025 00:01 UTC |
Karydas DaphneDirector
|
SaleCommon Stock | 4,885 | $46.36 | $226,446.13 |
DisclosureSEC source: 0001933414-25-000150 · wk-form4_1763078481.xml · nonDerivative · entry 3 Karydas Daphne · CIK 0001816952 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $46.19 to $46.70. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 00:01 UTC |
Karydas DaphneDirector
|
SaleCommon Stock | 10,115 | $45.81 | $463,350.95 |
DisclosureSEC source: 0001933414-25-000150 · wk-form4_1763078481.xml · nonDerivative · entry 2 Karydas Daphne · CIK 0001816952 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,885 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $45.19 to $46.18. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 00:01 UTC |
Karydas DaphneDirector
|
Exercise / conversionCommon Stock | 15,000 | $10.20 | $153,000.00 |
DisclosureSEC source: 0001933414-25-000150 · wk-form4_1763078481.xml · nonDerivative · entry 1 Karydas Daphne · CIK 0001816952 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 19:01 UTC |
Gold Alexander MDirector
|
Exercise / conversionStock Option · Derivative | 6,933 | $0.00 Strike: $10.20 | $0.00 |
DisclosureSEC source: 0001933414-25-000149 · wk-form4_1763078474.xml · derivative · entry 11 Gold Alexander M · CIK 0002026429 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,967 Underlying: Common Stock · 6,933 shares Expires 2035-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option vests in 12 monthly installments following the date of grant. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 19:01 UTC |
Gold Alexander MDirector
|
SaleCommon Stock | 1,933 | $47.28 | $91,385.67 |
DisclosureSEC source: 0001933414-25-000149 · wk-form4_1763078474.xml · nonDerivative · entry 6 Gold Alexander M · CIK 0002026429 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 19:01 UTC |
Gold Alexander MDirector
|
SaleCommon Stock | 5,000 | $46.50 | $232,500.00 |
DisclosureSEC source: 0001933414-25-000149 · wk-form4_1763078474.xml · nonDerivative · entry 5 Gold Alexander M · CIK 0002026429 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,933 Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 19:01 UTC |
Gold Alexander MDirector
|
Exercise / conversionCommon Stock | 6,933 | $10.20 | $70,716.60 |
DisclosureSEC source: 0001933414-25-000149 · wk-form4_1763078474.xml · nonDerivative · entry 4 Gold Alexander M · CIK 0002026429 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:01 UTC |
Gold Alexander MDirector
|
Exercise / conversionStock Option · Derivative | 15,000 | $0.00 Strike: $10.20 | $0.00 |
DisclosureSEC source: 0001933414-25-000149 · wk-form4_1763078474.xml · derivative · entry 10 Gold Alexander M · CIK 0002026429 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,900 Underlying: Common Stock · 15,000 shares Expires 2035-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option vests in 12 monthly installments following the date of grant. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:01 UTC |
Gold Alexander MDirector
|
SaleCommon Stock | 5,000 | $47.08 | $235,408.00 |
DisclosureSEC source: 0001933414-25-000149 · wk-form4_1763078474.xml · nonDerivative · entry 3 Gold Alexander M · CIK 0002026429 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:01 UTC |
Gold Alexander MDirector
|
SaleCommon Stock | 10,000 | $42.43 | $424,298.00 |
DisclosureSEC source: 0001933414-25-000149 · wk-form4_1763078474.xml · nonDerivative · entry 2 Gold Alexander M · CIK 0002026429 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:01 UTC |
Gold Alexander MDirector
|
Exercise / conversionCommon Stock | 15,000 | $10.20 | $153,000.00 |
DisclosureSEC source: 0001933414-25-000149 · wk-form4_1763078474.xml · nonDerivative · entry 1 Gold Alexander M · CIK 0002026429 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:01 UTC |
Levy Adam ScottCFO and Secretary
|
Exercise / conversionStock Option · Derivative | 6,613 | $0.00 Strike: $15.44 | $0.00 |
DisclosureSEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · derivative · entry 17 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,888 Underlying: Common Stock · 6,613 shares Expires 2033-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The stock option vests as to 25% of the total number of shares of common stock subject to the option on the first anniversary of the grant date, and as to 1/48th of the total number of shares of common stock subject to the option on each monthly anniversary thereafter. F15 · balance_after: Since the date of the Reporting Person's last ownership report, 8,499 stock options were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:01 UTC |
Levy Adam ScottCFO and Secretary
|
Exercise / conversionStock Option · Derivative | 44,079 | $0.00 Strike: $14.25 | $0.00 |
DisclosureSEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · derivative · entry 16 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,592 Underlying: Common Stock · 44,079 shares Expires 2034-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The stock option vests as to 25% of the total number of shares of common stock subject to the option on the first anniversary of the grant date, and as to 1/48th of the total number of shares of common stock subject to the option on each monthly anniversary thereafter. F14 · balance_after: Since the date of the Reporting Person's last ownership report, 64,329 stock options were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:01 UTC |
Levy Adam ScottCFO and Secretary
|
Exercise / conversionStock Option · Derivative | 34,414 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · derivative · entry 15 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,662 Underlying: Common Stock · 34,414 shares Expires 2033-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The stock option vests as to 25% of the total number of shares of common stock subject to the option on the first anniversary of the grant date, and as to 1/48th of the total number of shares of common stock subject to the option on each monthly anniversary thereafter. F13 · balance_after: Since the date of the Reporting Person's last ownership report, 42,442 stock options were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:01 UTC |
Levy Adam ScottCFO and Secretary
|
Exercise / conversionStock Option · Derivative | 20,547 | $0.00 Strike: $10.20 | $0.00 |
DisclosureSEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · derivative · entry 14 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,674 Underlying: Common Stock · 20,547 shares Expires 2035-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month period following the date of grant. F11 · balance_after: Since the date of the Reporting Person's last ownership report, 13,779 stock options were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:01 UTC |
Levy Adam ScottCFO and Secretary
|
SaleCommon Stock | 32,718 | $46.88 | $1,533,976.89 |
DisclosureSEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 13 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,396 F9 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $46.4900 to $47.3600. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (9) to this Form 4. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:01 UTC |
Levy Adam ScottCFO and Secretary
|
SaleCommon Stock | 38,900 | $45.93 | $1,786,587.53 |
DisclosureSEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 12 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,114 F8 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $45.4800 to $46.4725. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (8) to this Form 4. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:01 UTC |
Levy Adam ScottCFO and Secretary
|
SaleCommon Stock | 8,456 | $45.18 | $382,046.31 |
DisclosureSEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 11 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,014 F7 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $44.4700 to $45.4600. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (7) to this Form 4. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:01 UTC |
Levy Adam ScottCFO and Secretary
|
SaleCommon Stock | 4,142 | $43.50 | $180,183.21 |
DisclosureSEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 10 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,470 F6 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.1700 to $44.0500. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6) to this Form 4. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:01 UTC |
Levy Adam ScottCFO and Secretary
|
SaleCommon Stock | 8,485 | $42.34 | $359,258.29 |
DisclosureSEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 9 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,612 F5 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.1000 to $43.0400. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:01 UTC |
Levy Adam ScottCFO and Secretary
|
SaleCommon Stock | 12,952 | $41.65 | $539,479.29 |
DisclosureSEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 8 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,097 F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.0550 to $42.0400. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:01 UTC |
Levy Adam ScottCFO and Secretary
|
SaleCommon Stock | 1,561 | $42.68 | $66,622.54 |
DisclosureSEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 7 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,049 F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.5100 to $42.9150. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:01 UTC |
Levy Adam ScottCFO and Secretary
|
SaleCommon Stock | 11,295 | $41.87 | $472,931.82 |
DisclosureSEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 6 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,610 F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.4500 to $42.2800. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:01 UTC |
Levy Adam ScottCFO and Secretary
|
SaleCommon Stock | 1,015 | $42.00 | $42,630.00 |
DisclosureSEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 5 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,905 Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:01 UTC |
Levy Adam ScottCFO and Secretary
|
Exercise / conversionCommon Stock | 6,613 | $15.44 | $102,104.72 |
DisclosureSEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 4 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,920 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:01 UTC |
Levy Adam ScottCFO and Secretary
|
Exercise / conversionCommon Stock | 44,079 | $14.25 | $628,125.75 |
DisclosureSEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 3 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:01 UTC |
Levy Adam ScottCFO and Secretary
|
Exercise / conversionCommon Stock | 34,414 | $16.00 | $550,624.00 |
DisclosureSEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 2 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:01 UTC |
Levy Adam ScottCFO and Secretary
|
Exercise / conversionCommon Stock | 20,547 | $10.20 | $209,579.40 |
DisclosureSEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 1 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Since the date of the Reporting Person's last ownership report, 83,598 shares of common stock were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse. Read SEC document |
| November 11, 2025 Filed Nov 14, 2025 00:01 UTC |
Congleton JonDirector · Chief Executive Officer
|
SaleCommon Stock | 32,850 | $46.89 | $1,540,211.67 |
DisclosureSEC source: 0001933414-25-000151 · wk-form4_1763078487.xml · nonDerivative · entry 6 Congleton Jon · CIK 0001644975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 631,305 F6 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $46.4400 to $47.4191. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6) to this Form 4. Read SEC document |
| November 11, 2025 Filed Nov 14, 2025 00:01 UTC |
Congleton JonDirector · Chief Executive Officer
|
SaleCommon Stock | 112,275 | $45.83 | $5,145,956.21 |
DisclosureSEC source: 0001933414-25-000151 · wk-form4_1763078487.xml · nonDerivative · entry 5 Congleton Jon · CIK 0001644975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 664,155 F5 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $45.4300 to $46.4200. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4. Read SEC document |
| November 11, 2025 Filed Nov 14, 2025 00:01 UTC |
Congleton JonDirector · Chief Executive Officer
|
SaleCommon Stock | 29,207 | $45.20 | $1,320,165.16 |
DisclosureSEC source: 0001933414-25-000151 · wk-form4_1763078487.xml · nonDerivative · entry 4 Congleton Jon · CIK 0001644975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 776,430 F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $44.4800 to $45.4297. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. Read SEC document |
| November 11, 2025 Filed Nov 14, 2025 00:01 UTC |
Congleton JonDirector · Chief Executive Officer
|
SaleCommon Stock | 4,000 | $43.50 | $173,983.60 |
DisclosureSEC source: 0001933414-25-000151 · wk-form4_1763078487.xml · nonDerivative · entry 3 Congleton Jon · CIK 0001644975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 805,637 F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.1700 to $44.0500. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. Read SEC document |
| November 11, 2025 Filed Nov 14, 2025 00:01 UTC |
Congleton JonDirector · Chief Executive Officer
|
SaleCommon Stock | 8,862 | $42.31 | $374,946.79 |
DisclosureSEC source: 0001933414-25-000151 · wk-form4_1763078487.xml · nonDerivative · entry 2 Congleton Jon · CIK 0001644975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 809,637 F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.0500 to $43.0400. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| November 11, 2025 Filed Nov 14, 2025 00:01 UTC |
Congleton JonDirector · Chief Executive Officer
|
SaleCommon Stock | 12,806 | $41.64 | $533,235.44 |
DisclosureSEC source: 0001933414-25-000151 · wk-form4_1763078487.xml · nonDerivative · entry 1 Congleton Jon · CIK 0001644975 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 818,499 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.0500 to $42.0000. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
| October 15, 2025 Filed Oct 15, 2025 23:04 UTC |
Rodman David MalcomChief Medical Officer
|
SaleCommon Stock | 10,369 | $43.01 | $445,982.10 |
DisclosureSEC source: 0001933414-25-000128 · wk-form4_1760569464.xml · nonDerivative · entry 1 Rodman David Malcom · CIK 0001672659 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,155 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 25, 2024. F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.8000 to $43.1950. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| October 13, 2025 Filed Oct 15, 2025 19:04 UTC |
Levy Adam ScottCFO and Secretary
|
SaleCommon Stock | 3,392 | $42.26 | $143,332.69 |
DisclosureSEC source: 0001933414-25-000130 · wk-form4_1760569476.xml · nonDerivative · entry 2 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,865 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2023. F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.1600 to $42.3400. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. Read SEC document |
| October 13, 2025 Filed Oct 15, 2025 19:04 UTC |
Levy Adam ScottCFO and Secretary
|
SaleCommon Stock | 7,366 | $41.90 | $308,650.87 |
DisclosureSEC source: 0001933414-25-000130 · wk-form4_1760569476.xml · nonDerivative · entry 1 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,257 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2023. F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.1362 to $42.1300. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Since the date of the Reporting Person's last ownership report, 5,311 shares of common stock were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse. Read SEC document |
| October 13, 2025 Filed Oct 15, 2025 23:04 UTC |
Congleton JonDirector · Chief Executive Officer
|
SaleCommon Stock | 1,552 | $43.03 | $66,782.40 |
DisclosureSEC source: 0001933414-25-000129 · wk-form4_1760569470.xml · nonDerivative · entry 2 Congleton Jon · CIK 0001644975 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 831,305 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024. F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.9822 to $43.2030. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. Read SEC document |
| October 13, 2025 Filed Oct 15, 2025 23:04 UTC |
Congleton JonDirector · Chief Executive Officer
|
SaleCommon Stock | 13,548 | $42.63 | $577,544.47 |
DisclosureSEC source: 0001933414-25-000129 · wk-form4_1760569470.xml · nonDerivative · entry 1 Congleton Jon · CIK 0001644975 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 832,857 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024. F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.9800 to $42.9800. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| September 15, 2025 Filed Sep 16, 2025 22:54 UTC |
Rodman David MalcomChief Medical Officer
|
SaleCommon Stock | 2,065 | $36.47 | $75,320.46 |
DisclosureSEC source: 0001672659-25-000006 · wk-form4_1758063276.xml · nonDerivative · entry 2 Rodman David Malcom · CIK 0001672659 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 81,524 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 25, 2024. F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $36.4026 to $36.7005. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. Read SEC document |
| September 15, 2025 Filed Sep 16, 2025 22:54 UTC |
Rodman David MalcomChief Medical Officer
|
SaleCommon Stock | 9,302 | $35.90 | $333,945.52 |
DisclosureSEC source: 0001672659-25-000006 · wk-form4_1758063276.xml · nonDerivative · entry 1 Rodman David Malcom · CIK 0001672659 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,589 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 25, 2024. F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $35.4000 to $36.3955. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| September 04, 2025 Filed Sep 9, 2025 00:07 UTC |
AKKARAJU SRINIVASDirector
|
PurchaseCommon Stock | 588,235 | $25.50 | $14,999,992.50 |
DisclosureSEC source: 0001415889-25-023919 · form4-09092025_120910.xml · nonDerivative · entry 1 AKKARAJU SRINIVAS · CIK 0001253170 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Samsara Opportunity Fund, L.P. Disclosed balance after: 588,235 F1 · ownership.nature: Securities are directly held by Samsara Opportunity Fund, L.P. ("Samsara Opp LP"). Samsara Opportunity Fund GP, LLC ("Samsara Opp GP") is the general partner of Samsara Opp LP and may be deemed to beneficially own the securities held by Samsara Opp LP. The Reporting Person has voting and investment power over the shares held by Samsara Opp LP and, accordingly, may be deemed to beneficially own the shares held by Samsara Opp LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 21:59 UTC |
RA CAPITAL MANAGEMENT, L.P.Director
RA Capital Healthcare Fund LPDirector
RA Capital Nexus Fund III, L.P.Director
Kolchinsky PeterDirector
Shah Rajeev M.Director
|
PurchaseCommon Stock | 1,176,470 | $25.50 | $29,999,985.00 |
DisclosureSEC source: 0001415889-25-023893 · form4-09082025_090941.xml · nonDerivative · entry 1 RA CAPITAL MANAGEMENT, L.P. · CIK 0001346824 · Director RA Capital Healthcare Fund LP · CIK 0001315082 · Director RA Capital Nexus Fund III, L.P. · CIK 0001883840 · Director Kolchinsky Peter · CIK 0001384859 · Director Shah Rajeev M. · CIK 0001619841 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 5,456,521 F1 · ownership.nature: Held directly by the RA Capital Healthcare Fund, L.P. (the "Fund"). F2 · ownership.nature: RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and RA Capital Nexus Fund III, L.P. (the "Nexus Fund III"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, the Fund, the Nexus Fund III, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. Read SEC document |
| August 13, 2025 Filed Aug 14, 2025 22:02 UTC |
Rodman David MalcomChief Medical Officer
|
SaleCommon Stock | 11,365 | $12.93 | $146,986.95 |
DisclosureSEC source: 0001933414-25-000093 · wk-form4_1755208973.xml · nonDerivative · entry 2 Rodman David Malcom · CIK 0001672659 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,891 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 25, 2024. F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.590 to $13.223. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 22:02 UTC |
Rodman David MalcomChief Medical Officer
|
Exercise / conversionStock Option · Derivative | 6,349 | $0.00 Strike: $1.08 | $0.00 |
DisclosureSEC source: 0001933414-25-000093 · wk-form4_1755208973.xml · derivative · entry 3 Rodman David Malcom · CIK 0001672659 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,531 Underlying: Common Stock · 6,349 shares Expires 2032-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 25, 2024. F3 · derivative.exercise_date: The stock option vested as to 25% of the underlying shares on July 12, 2022, with the remaining shares vesting in 36 substantially equal monthly installments thereafter. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 22:02 UTC |
Rodman David MalcomChief Medical Officer
|
Exercise / conversionCommon Stock | 6,349 | $1.08 | $6,856.92 |
DisclosureSEC source: 0001933414-25-000093 · wk-form4_1755208973.xml · nonDerivative · entry 1 Rodman David Malcom · CIK 0001672659 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 25, 2024. Read SEC document |
| July 30, 2025 Filed Jul 30, 2025 20:12 UTC |
Levy Adam ScottCFO and Secretary
|
SaleCommon Stock | 8,425 | $15.10 | $127,203.18 |
DisclosureSEC source: 0001933414-25-000081 · wk-form4_1753920718.xml · nonDerivative · entry 4 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,934 F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.063 to $15.130. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. Read SEC document |
| July 30, 2025 Filed Jul 30, 2025 20:12 UTC |
Levy Adam ScottCFO and Secretary
|
SaleCommon Stock | 51,500 | $14.70 | $757,168.45 |
DisclosureSEC source: 0001933414-25-000081 · wk-form4_1753920718.xml · nonDerivative · entry 3 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,359 F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.06 to $15.06. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. Read SEC document |
| July 29, 2025 Filed Jul 30, 2025 20:12 UTC |
Levy Adam ScottCFO and Secretary
|
SaleCommon Stock | 807 | $14.00 | $11,301.87 |
DisclosureSEC source: 0001933414-25-000081 · wk-form4_1753920718.xml · nonDerivative · entry 2 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,859 F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.01. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:12 UTC |
Levy Adam ScottCFO and Secretary
|
SaleCommon Stock | 12,946 | $14.04 | $181,803.27 |
DisclosureSEC source: 0001933414-25-000081 · wk-form4_1753920718.xml · nonDerivative · entry 1 Levy Adam Scott · CIK 0001693134 · CFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 193,666 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.20. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.